APA (7th ed.) Citation

Wykoff, C. C., Rosenfeld, P. J., Waheed, N. K., Singh, R. P., Ronca, N., Slakter, J. S., . . . Ribeiro, R. (2021). Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy. Ophthalmology (Rochester, Minn.), 128(9), 1325. https://doi.org/10.1016/j.ophtha.2021.02.025

Chicago Style (17th ed.) Citation

Wykoff, Charles C., et al. "Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy." Ophthalmology (Rochester, Minn.) 128, no. 9 (2021): 1325. https://doi.org/10.1016/j.ophtha.2021.02.025.

MLA (9th ed.) Citation

Wykoff, Charles C., et al. "Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy." Ophthalmology (Rochester, Minn.), vol. 128, no. 9, 2021, p. 1325, https://doi.org/10.1016/j.ophtha.2021.02.025.